MBK Partners will make a partial exit from ING Life Korea as the insurer raises KRW1.1 billion ($972 million) in its domestic IPO.
Capacite Infraprojects, an Indian construction firm backed by Paragon Partners and NewQuest Capital Partners, has filed for a INR4 billion ($62 million) IPO.
KKR’s first close dominates fundraising activity, but mid-market showing still impresses; Japan leads the way as Asia exits remain reasonably strong; investment slows, if China state-backed deals are ignored
Apax Partners has agreed to invest $388 million in Guotai Junan Securities as the largest cornerstone investor in the Chinese brokerage’s HK$16.5 billion ($2.1 billion) Hong Kong IPO.
China’s Minsheng Education Group closed up 9.4% on its first day of trading in Hong Kong, following a HK$1.38 billion ($177 million) IPO in which the International Finance Corporation (IFC) participated as a cornerstone investor.
Hospital Corporation of China (HCC), a hospital operation group established by Hony Capital, has launched a Hong Kong IPO that would see the company raise as much as HK$500 million ($64 million).
China’s largest express delivery services provider SF Express, which is backed by several PE investors, has completed a backdoor listing in Shenzhen that values the business at RMB43.3 billion ($6.6 billion).
Sushiro Global Holdings, a sushi restaurant chain majority-owned by Permira, is looking to raise up to JPY82.4 billion ($728 million) through an IPO in Tokyo.
ING Life Korea, a Korean insurer that MBK Partners acquired in 2013 from ING Groep, has applied for regulatory approval for a domestic IPO.
Indian pharmaceutical company Eris Lifesciences has filed for a domestic IPO that is expected to facilitate a full exit for ChrysCapital Partners, which has been an investor since 2011.
Serba Dinamik Holdings, a Malaysian oil and gas services provider backed by CMS Opus Private Equity (COPE), posted a marginal gain on its first day of trading on the Bursa Malaysia after raising MYR600 million ($135 million) in its IPO.
Indian non-banking financial company (NBFC) Au Financiers has filed for an IPO, providing partial exits for its PE backers including Warburg Pincus, ChrysCapital, Kedaara Capital and the International Finance Corporation (IFC).
Ausgrid deal obscures weak investment environment; fundraising returns to normal after state-backed blitz; China’s IPO market is on the mend, but public market problems undermine Asia exits
Fifteen start-ups backed by IDG Capital Partners achieved valuations of $1 billion or more in 2016, taking the total number of unicorns in the China-focused VC firm’s portfolio to 26 over the past 12 years.
New Century Healthcare, a Chinese pediatric hospital operator backed by CDH Investments and Boyu Capital, is planning to raise HK$1 billion ($129 million) via a Hong Kong IPO.
From re-listing Focus Media in Shenzhen to closing Fund III at $2.1 billion, FountainVest Partners has enjoyed a fruitful 12 months. CEO Frank Tang assesses the China market
Moving from a privatization in the US to a re-listing in Shenzhen through a reverse merger – in the space of 30 months – Focus Media blazed a trail that others have sought to follow
Everstone Capital is set to make a partial exit from Indian educational publisher S Chand as the company filed for domestic IPO.
Meitu, a Chinese photo and community app provider driven by the selfie phenomenon, raised HK$4.88 billion ($629 million) in its Hong Kong IPO, securing liquidity events for several venture capital investors.
Infrastructure and late-stage technology among the few investment bright spots; renminbi vehicles dominate the fundraising landscape; public market instability undermines exit plans
Exit opportunities are available for savvy investors in India, and market professionals say prospects are good in the long term. But GPs are likely to continue to find the near future difficult
PNB Housing Finance, the mortgage lender subsidiary of India's state-run Punjab National Bank that is backed by The Carlyle Group, closed up 11.35% on its trading debut following a INR30 billion ($449 million) IPO.
Betta Pharmaceuticals, a Chinese VC-backed drug developer backed by several venture investors, has completed a RMB720 million ($106 million) IPO on Shenzhen’s Growth Enterprise Market Board.
Ingham’s Enterprises, an Australian poultry producer bought by TPG Capital three years ago, has scaled back its domestic IPO to a target of A$596.4 million ($457 million).